Obestatin and ghrelin in obese and in pregnant women

Peptides

Volumn 28, Issue 10, 2007, Pages 1937-1944

  Fontenot, Elizabeth ^a   DeVente, J E ^a   Seidel, E R ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Diabetes; Ghrelin; GIP; GLP 1; Human adipose tissue; Obesity; Obestatin; Pregnant; PYY

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; HORMONE RECEPTOR; INCRETIN; MESSENGER RNA; OBESTATIN; OBESTATIN RECEPTOR; PEPTIDE YY; PROTEIN GHSR 1A; PROTEIN GPR 39; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOCYTE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OBESITY; OMENTUM; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL;

BASE SEQUENCE; BODY MASS INDEX; COHORT STUDIES; DNA PRIMERS; FEMALE; GHRELIN; HUMANS; IMMUNOHISTOCHEMISTRY; OBESITY; PREGNANCY; RADIOIMMUNOASSAY; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 34548665483     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.08.005     Document Type: Article

References (28)

1. Ahren B. GLP-1 and extra-islet effects. Horm Metab Res 36 (2004) 842-845
2. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
3. Broglio F., Prodam F., Me E., Riganti F., Lucatello B., Granata R., et al. Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest 28 (2005) 23-25
4. Broglio F., Prodam F., Riganti F., Muccioli G., and Ghigo E. Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions. Front Horm Res 35 (2006) 102-114
5. Castan I., Valet P., Larrouy D., Voisin T., Remaury A., Daviaud D., et al. Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the alpha 2-adrenergic system. Am J Physiol 265 (1993) E74-E80
6. Chartrel N., vear-Perez R., Leprince J., Iturrioz X., Reaux-Le G.A., Audinot V., et al. Comment on "obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766
7. Ginty D.D., Marlowe M., Pekala P.H., and Seidel E.R. Multiple pathways for the regulation of ornithine decarboxylase in intestinal epithelial cells. Am J Physiol 258 (1990) G454-G460
8. Haider D.G., Schindler K., Prager G., Bohdjalian A., Luger A., Wolzt M., et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92 (2007) 1168-1171
9. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., et al. GPR-39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology (2006)
10. Holst J.J., Fahrenkrug J., Stadil F., and Rehfeld J.F. Gastrointestinal endocrinology. Scand J Gastroenterol Suppl 216 (1996) 27-38
11. Kim B.J., Carlson O.D., Jang H.J., Elahi D., Berry C., and Egan J.M. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab 90 (2005) 6665-6671
12. Korner J., Bessler M., Cirilo L.J., Conwell I.M., Daud A., Restuccia N.L., et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90 (2005) 359-365
13. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR-39. Biochem Biophys Res Commun 351 (2006) 21-25
14. Le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147 (2006) 3-8
15. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
16. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 39 (2002) 781-784
17. Muccioli G., Pons N., Ghe C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 498 (2004) 27-35
18. Murphy K.G., and Bloom S.R. Gut hormones and the regulation of energy homeostasis. Nature 444 (2006) 854-859
19. Park W.H., Oh Y.J., Kim G.Y., Kim S.E., Paik K.H., Han S.J., et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab 92 (2007) 229-234
20. Rehfeld J.F. The new biology of gastrointestinal hormones. Physiol Rev 78 (1998) 1087-1108
21. Sancho V., Trigo M.V., Gonzalez N., Valverde I., Malaisse W.J., and Villanueva-Penacarrillo M.L. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats. J Mol Endocrinol 35 (2005) 27-38
22. Sancho V., Trigo M.V., Martin-Duce A., Gonz L.N., Acitores A., Arnes L., et al. Effect of GLP-1 on d-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects. Int J Mol Med 17 (2006) 1133-1137
23. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90 (2005) 2161-2168
24. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116 (2006) 1983-1993
25. Valet P., Berlan M., Beauville M., Crampes F., Montastruc J.L., and Lafontan M. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J Clin Invest 85 (1990) 291-295
26. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
27. Yip R.G., and Wolfe M.M. GIP biology and fat metabolism. Life Sci 66 (2000) 91-103
28. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999